Company intelligence / Profile preview

DIO

Morrisville, North Carolina, United Statesronniejamesdio.com ↗

Ownership: Private
Development stage: Other

Overview

FUJIFILM Diosynth Biotechnologies is one of the world's largest contract manufacturers of biopharmaceuticals, providing end-to-end development and manufacturing services for biologics, vaccines, advanced therapies, and cell therapies. The company operates globally with major facilities in the US and Europe. It has recently expanded its capabilities in Denmark and California to support large-scale production needs. In April 2025, it signed a $3 billion+ ten-year manufacturing agreement with Regeneron Pharmaceuticals to provide U.S.-based production of leading biologic medicines.

Modalities: ProteinmRNA-based drugsVaccineCell therapy
Industry: Contract Manufacturing Organization

Partnerships

Regeneron Pharmaceuticals ($3B+, long-term U.S. supply agreement)

Beyond the preview

Go deeper on DIO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DIO.

Explore the full profile